)
)
Astria Therapeutics Investor Relations Material
Latest events
Study Result
Astria Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Astria Therapeutics Inc
Access all reports
Astria Therapeutics Inc., formerly known as Catabasis Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases. The company's lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein. Astria Therapeutics is headquartered in Boston, Massachusetts, and its shares are listed on the Nasdaq.
Key slides for Astria Therapeutics Inc
Corporate Presentation
Astria Therapeutics Inc
Corporate Presentation
Astria Therapeutics Inc
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
ATXS
Country
🇺🇸 United States